Hydralazine Hydrochloride
- Product NDC
- 17478-834
- 11-digit product format
- 174780834
- Labeler code
- 17478
- Product ID
- 17478-834_547ca932-b451-44de-b6c2-ad98b1b7c96b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydralazine Hydrochloride
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Akorn, Inc.
- Application
- ANDA040730
- Marketing category
- ANDA
- Marketing start
- 2013-02-21
- Marketing end
- 0000-00-00
- Substance
- HYDRALAZINE HYDROCHLORIDE
- Active strength
- 20 mg/mL
- Pharmacologic classes
- Arteriolar Vasodilation [PE],Arteriolar Vasodilator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 17478-834-01 | 17478083401 | 10 VIAL, SINGLE-DOSE in 1 CARTON (17478-834-01) > 1 mL in 1 VIAL, SINGLE-DOSE | 2013-02-21 | 0000-00-00 | No | No | Current |
| 17478-834-15 | 17478083415 | 25 VIAL, SINGLE-DOSE in 1 CARTON (17478-834-15) > 1 mL in 1 VIAL, SINGLE-DOSE | 2013-02-21 | 0000-00-00 | No | No | Current |